Feeds › Clinical trial updates
Clinical trial updates
Drug and device trials that companies register on ClinicalTrials.gov: newly completed phase 3 studies, changes of status and the dates a study is due to finish.
About this data
- What it is
- ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
- Who files it
- The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
- How current
- We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
- Terms
- ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
- Worth knowing
- A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
- Not to be confused with
- FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.
All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.
Source and freshness · Information, not investment advice (disclaimer).
Studies updated per day, last 30 days
All industry-sponsored studies Sponsor matched to a public company
By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.
Latest clinical trial updates
Showing: ticker LIVN · All recent updates
Studies by the date their record was last updated.
| Updated | Study | SponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private. | PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages. | StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time). | Enrolled | Primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update. | Source |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effec… NCT03887715 · Treatment Resistant Depression Vagus Nerve Stimulation (VNS) | LIVN LivaNova | Not applicable | Recruiting | 6,800 | Feb 28, 2028 | Registry ↗ |
| Aug 27, 2026 | A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat D… NCT03320304 · Treatment Resistant Depression Vagal Nerve Simulation (VNS) Therapy | LIVN LivaNova | — | Recruiting | 500 | Dec 1, 2029 | Registry ↗ |
| Jul 17, 2026 | Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation NCT04950894 · Obstructive Sleep Apnea, OSA Hypoglossal Nerve Stimulation | LIVN LivaNova | Not applicable | Completed | 107 | Oct 17, 2024 | Registry ↗ |
| Mar 25, 2026 | Non-interventional Study Describing Healthcare Resource Utilisation and Clinical Outcomes Associate… NCT04779814 · Epilepsy | LIVN LivaNova | — | Terminated | 97 | Aug 19, 2025 | Registry ↗ |
| Dec 20, 2024 | The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will p… NCT04753385 · Treatment Resistant Depression | LIVN LivaNova | — | Terminated | 138 | Sep 6, 2024 | Registry ↗ |
| Dec 3, 2024 | IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes. NCT05975931 · Epilepsy | LIVN LivaNova | — | Terminated | 15 | Jan 30, 2024 | Registry ↗ |
| Nov 22, 2024 | Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. NCT03529045 · Epilepsy, Seizures Vagus Nerve Stimulation (VNS) Therapy | LIVN LivaNova | — | Completed | 827 | Sep 11, 2024 | Registry ↗ |
| Oct 10, 2023 | ANTHEM-HFrEF Pivotal Study NCT03425422 · Heart Failure, Heart Failure, Congestive VITARIA System | LIVN LivaNova | Not applicable | Terminated | 533 | May 31, 2023 | Registry ↗ |
| Oct 25, 2022 | Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study NCT03446664 · Epilepsies, Partial, Epilepsy, Tonic-Clonic Microburst Stimulation | LIVN LivaNova | Not applicable | Completed | 33 | Jul 30, 2021 | Registry ↗ |
| Aug 25, 2020 | XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU) NCT04282681 · Epilepsy, Tonic-Clonic Accelerometer Live-Streaming Tool | LIVN LivaNova | — | Withdrawn | 0 | Aug 28, 2021 | Registry ↗ |
| Feb 20, 2020 | Mitroflow DL Post Approval Study- North America NCT02351726 · Aortic Stenosis, Aortic Regurgitation Mitroflow DL | LIVN LivaNova | Not applicable | Terminated | 186 | Dec 31, 2019 | Registry ↗ |
| May 28, 2019 | Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm (LEVEA) NCT03014180 · Heart Failure "In-Clinic LVAT" | LIVN LivaNova | Not applicable | Completed | 60 | Aug 17, 2017 | Registry ↗ |
| Mar 13, 2018 | VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients NCT02113033 · Heart Failure With Reduced Ejection Fraction Equilia® Vagal Nerve Stimulation | LIVN LivaNova | Phase 2 | Completed | 15 | Feb 22, 2016 | Registry ↗ |
| Mar 13, 2018 | Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation (LENEA) NCT01731210 · LV Lead, LV Therapy implantation of the new LV lead: NANO system. | LIVN LivaNova | Phase 2/3 | Terminated | 9 | — | Registry ↗ |
| Nov 14, 2017 | Sleep Apnea, Arrhythmias and Cardiac Reverse Remodeling in Heart Failure Patients NCT02870647 · Sleep Breathing Disorders in the Responders to Cardiac Resy… Echocardiographic, polygraphy, electrocardiography measurem… | LIVN LivaNova | Phase 4 | Withdrawn | 0 | Jun 2019 | Registry ↗ |
| Nov 14, 2017 | Optimization With SonR Method in the ClinicAl pRactice NCT02250547 · CRT Patients | LIVN LivaNova | — | Completed | 278 | Jan 2017 | Registry ↗ |
| Nov 14, 2017 | Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers NCT00531037 · Patients Implanted With a Pacemaker | LIVN LivaNova | — | Completed | 1,440 | Dec 2011 | Registry ↗ |
| Oct 18, 2017 | Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode NCT02586480 · Sinus Node Dysfunction, Atrioventricular Block dual chamber pacemaker with SafeR algorithm | LIVN LivaNova | — | Completed | 848 | Nov 2015 | Registry ↗ |
| Oct 5, 2017 | PErsonalized and Adaptive Kinesthetic stImulation Therapy, Based on Cardio-respiratory Holter moNit… NCT02789748 · Obstructive Sleep Apnea Syndrome Kinesthetic stimulation | LIVN LivaNova | Not applicable | Completed | 42 | Oct 2, 2017 | Registry ↗ |
| Oct 3, 2017 | HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor NCT03300037 · Sleep Apnea, Obstructive Kinesthetic stimulation | LIVN LivaNova | — | Completed | 46 | Apr 16, 2015 | Registry ↗ |
| Apr 25, 2017 | Left Ventricular Pacing Vectors Effectiveness to Narrow Phrenic Nerve Stimulation NCT03127202 · Heart Failure Cardiac Resynchronization Therapy -Defibrillator (range PAR… | LIVN LivaNova | Not applicable | Completed | 90 | Dec 2015 | Registry ↗ |
| Apr 6, 2017 | The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice NCT02577445 · Sleep Apnea, Central Sleep Disordered Breathing | LIVN LivaNova | — | Terminated | 31 | Oct 2016 | Registry ↗ |
| Dec 3, 2015 | Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients NCT01169896 · Ventricular Tachycardia, Ventricular Fibrillation | LIVN LivaNova | — | Completed | 616 | Dec 2011 | Registry ↗ |
| Jan 13, 2015 | Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without P… NCT00729703 · Tachycardia Ovatio DR 6550, OVATIO DR 6550 | LIVN LivaNova | Phase 4 | Completed | 462 | Dec 2011 | Registry ↗ |
| Jan 12, 2015 | Clinical Status Monitoring in Implantable Cardiac Defibrillator (ICD) Patients by Physiological Dia… NCT01170624 · Heart Failure ICD | LIVN LivaNova | Phase 4 | Terminated | 388 | Sep 2011 | Registry ↗ |
| Jan 12, 2015 | Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications NCT00560768 · Sudden Cardiac Death Ovatio VR 6250 or DR6550 | LIVN LivaNova | Phase 4 | Completed | 198 | Aug 2012 | Registry ↗ |
26 items, most recent first (up to 50). Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 7:20 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances